PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0271051|macular edema |
| Sentences | 5 |
| PubMedID- 22876931 | Branch retinal vein occlusion (brvo) is a common retinal vascular disease that often leads to macular edema, which is the chief reason for visual impairment in brvo patients [1,2]. |
| PubMedID- 25140246 | Sustained-release corticosteroid treatment has shown to be a promising strategy for macular edema due to retinovascular disease (i.e., diabetes and retinal vein occlusion) and for the treatment of noninfectious posterior uveitis. |
| PubMedID- 25200895 | [switching to eylea in macular edema due to retinal vascular diseases]. |
| PubMedID- 23901258 | Branch retinal vein occlusion (brvo), a common retinal vascular disease, is often associated with macular edema, which is the most frequent cause of visual impairment in these patients.12 thus, it is critical to determine the cellular and molecular factors that underlie the pathogenesis of macular edema secondary to brvo. |
| PubMedID- 21386915 | Branch retinal vein occlusion (brvo) is a common retinal vascular disease that often leads to macular edema, which is the commonest reason for visual impairment in this disease.1,2 we recently reported that the ocular fluid levels of several molecules, including vascular endothelial growth factor (vegf), soluble intercellular adhesion molecule-1 (sicam-1), and pigment epithelium-derived factor (pedf), had an independent influence on retinal vascular permeability in brvo patients with macular edema.3,4 therefore, changes in the vitreous levels of these molecules may influence the development of macular edema associated with brvo and may also be related to improvement of macular edema in brvo patients after pars plana vitrectomy (ppv). |
Page: 1